Review: Screening, Diagnosis and Management of Gastric CarcinoidNina Behdin, Abubaker A. Ali and David Edelman*
Department of Surgery, Wayne State University, Detroit, MI 48201, USA
- *Corresponding Author:
- David Edelman, MD
Department of Surgery
6C-University Health Center
4201 Saint Antoine, Detroit
MI 48201, USA
E-mail: [email protected]
Received date: November 16, 2015 Accepted date: January 27, 2016 Published date: February 4, 2016
Citation: Behdin N, Ali AA, Edelman D (2016) Review: Screening, Diagnosis and Management of Gastric Carcinoid. J Gastrointest Dig Syst 6:384. doi:10.4172/2161-069X.1000384
Copyright: © 2016 Behdin N, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Gastric neuroendocrine tumors (NETs), formerly known as gastric carcinoids (GCs), are neoplasms derived from enterochromaffin cells of the stomach. This heterogeneous group of tumors has been historically divided into three types.